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Abstract  
Because human serum transferrin (hTF) 
exists freely in serum, it is a potential target 
for cancer treatment drugs and in curing 
iron-overloaded conditions in patients via 
long-term transfusion therapy.  The 
understanding of the interactions between 
hTF and metal ions is very important for 
biological, pharmalogical, toxicological, and other protein engineering purposes.  In 
this paper, a simple linear free energy correlation is proposed to predict the binding 
strength between hTF protein and metal cations. The stability constants (KML) for a 
family of metal—hTF complexes can be correlated to the non-solvation energies 
(G0n, Mn+) and the radii (rMn+) of cations by equation: 
2.303RTlogKML =  -a*ML G0n, Mn+ - b**ML - *ML rMn+  + G0f, Mn+,  
where the coefficients a*ML, b**ML, and *ML characterize a particular family of 
metal-protein complexes.  The binding strength is determined by both the physical 
properties (charge and size or ionic radius, rMn+) and chemical properties (non-
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solvation energy, G0n, Mn+) of a given cation. The binding strengths of either 
divalent or and trivalent metals can then be predicted systematically.  The predicted 
stability constants of Pu3+—hTF, Am3+—hTF, and Cm3+—hTF complexes are much 
lower than that of Fe3+—hTF complex. The predicted stability constants of Co3+—
hTF, Tl3+—hTF, Au3+—hTF, and Ru3+—hTF complexes are higher than that of the 
Fe3+—hTF complex.   
 
Key words: Metal- Protein complex, Human Serum Transferrin, Anticancer Metals, 
Solvation of Ions, Linear Free Energy Relationship, Actinides, Binding Strength, 
Metalloprotein   
 
 
Introduction 
 Human serum transferrin (hTF) is a single-chain glycoprotein that transports iron 
(Fe) in blood 1-4.  Human serum transferrin has a very strong binding force to bind metal 
ions, such as Fe3+, Ga3+, and Al3+.  The hTF molecule contains about 700 amino acids 
with molecular weight of about 80 kDa 2.  The M3+ cation binds with two Tyr, one His, 
one Asp, and one bidendate CO32-5, 6 7-11 12.  The coordination environment of the bonded 
metals is either an octahedron or a distorted octahedron 4, 6 7-11.  The anion CO32- is called 
a synergistic anion (Figure 1).  The M3+ cations cannot bind strongly without the 
synergistic anion 2, 5, 6 7-11.  Although the protein hTF is very complex and looks like 
poly-dendate ligands, it may be considered as a single hexadendate ligand, such as EDTA 
or ethylenebis (o-hydroxyphenyglycine).  The binding strength between metal ion and 
protein can be characterized by the stability constant of a metal-protein complex 5, 13, 14 15-
17.  The stability constants according to the reference are expressed as 5, 13, 17:  
K1 = [M3+—hTF]/[M3+][hTF],  
and  
K2 = [M3+—(hTF-M3+)]/[M3+][M3+- hTF].    
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Figure 1: Diagrams showing protein structure of hTF (upper) drawn by using 
ChemTube3D online program and the coordination environment of M3+ cations in the 
M3+—hTF complex (modified from references 6).  
 
Because human serum transferrin is only 30% saturated with Fe3+, the hTF has a high 
capacity to bind other metals 2 18 17. Therefore, it is important to understand the interaction 
between hTF and other metals, although it is very difficult to measure the stability 
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constants for metal-hTF complexes.  For instance, platinum and gold complexes are used 
as anticancer and anti-tumor agents 19-23, organometallic ruthenium Complexes are 
considered as a potential anti-cancer drug 24-28 29 30, and the metal ion Bi3+ is widely used 
for variety of gastrointestinal disorders including diarrhea, constipation, gastritis, and 
ulcers 31, 32 33 34 35 36 37 38.   There are limited number of stability constants for metal-hTF 
complexes and other metal-protein complexes 5 17, 39 40.  Binding constants for some 
redox-sensitive metals (e.g., Fe2+, Mn3+ and Co3+) are difficult to measure experimentally 
41, 42. Also, metals like Cm, Am, U and others metals associated with nuclear energy and 
weapons, are hazardous to human health, and it is imperative to be able to predict the 
transferring binding constants for these metals. These metals, however, are risky to 
perform experiments upon because of their transuranium radiation dangers) 2, 43.  The 
existing correlation methods for predicting the stability constants are generally based on 
the stability constants of metal complexes with small ligands or the hydrolysis constants 14 
16, which are generally not fully available, especially for metal cations like such as Pu3+, 
and Am3+.  In addition, the methods based on small ligand complexes could lead to large 
uncertainties between experimental values and predicted values, which could be as large 
as two to three log units for Fe3+, Bi3+, Cu2+, Gd3+, In3+, and Al3+ 14.  Therefore, there is a 
need for developing a tool that can give a reliable prediction of unknown stability 
constants that can also be based on the limited number of the existing measurements.  
Furthermore, as even more thermodynamic data for metal-protein complexes are 
accumulated, such a tool is also needed for the systematic evaluation of the quality of data 
collected from multiple sources to develop an internally consistent reliable data set for 
modeling metal-protein interactions. 
  
Proposed equation          
 Linear free energy relationships have been used for correlating organic reactions 
(Hammett equation) 44, stabilities of crystalline solids 45 46, and trace metals bindings at 
mineral-water interfaces 47.  A similar relationship can be also used for metal—protein 
binding because the coordination environment for a metal in transferin is much like the 
polyhedral coordination of metal cations in crystal structures 5, 6 7-11.  A family of metal-
proteins or metal-organic chelate refers to the complexes formed with different metals 
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with a given protein or organic ligand.  In each family, metal cations have the same 
charge.  A family of metal complexes can be represented by (Mn+L), where Mn+ is a 
cation with a charge +n, and L represents the ligand of the metal complex (e.g., in M3+—
hTF metal-protein complexes, the trivalent cations M3+ are Fe, Ga, Tl, etc., and L is hTF). 
The local coordination environment of metal cations in hTF is very similar to that of 
crystalline minerals like calcite. Because it is analogous to the crystalline structure of 
solids 45 46-48, the linear free energy correlation is expressed as: 
G0f, ML  = a*ML G0n, Mn+ + b*ML  -*ML rMn+,      (1a) 
where, G0f, ML is the Gibbs free energy of formation of the complex ML.  The stability 
of most metal complexes (metalloproteins), for a metal complexation reaction of Mn+ + L 
= Mn+L, is expressed as a stability constant given by 47: 
-2.303RT logKML = a*ML G0n, Mn+ + b*ML +*ML rMn+  - G0f, Mn+  - G0f, L      (1b) 
or, 
-2.303RT logKML = a*ML G0n, Mn+ + b**ML +*ML rMn+  - G0f, Mn+   (1c) 
or,  
logKML = -(a*ML G0n, Mn+ + b**ML +*ML rMn+  - G0f, Mn+ ) / 2.303RT  (1d) 
where,  
b**ML = b*ML - G0f, L .            (1e) 
 
In above equations, G0f, L is the Gibbs free energy of formation of a ligand L or, hTF,  
KML is the stability constants of a metal complexation reaction Mn+ + L = Mn+L, and the 
coefficients a*ML, b**ML, and *ML characterize a particular family of metal complexes 
Mn+L, which can be calculated by fitting equation (1c) to a limited number of 
experimentally determined log K values; rMn+ is the ionic radius of the Mn+ cation 
referring to six-fold coordination for divalent 49, trivalent and tetravalent cations 50, 51; 
KML is thermodynamic stability constant of a metal complex, and G0n, Mn+  is the 
standard non-solvation energy, corrected for cation radius 51.  Equation (1d) allows the 
prediction of the stability constant of a metal complex from the known thermodynamic 
properties of the corresponding metal cation.   
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 The non-solvation energy G0n, Mn+ that corresponds to the unhydrated cation 
energy, can be calculated by: 
 G0n, Mn+G0f, Mn+  - G0s, Mn+,         (2)  
where G0f, Mn+ and G0s, Mn+ represent the standard Gibbs free energy of formation and 
the standard solvation energy of a bare metal cation respectively. G0s, Mn+ can be 
calculated from the conventional Born solvation coefficients for aqueous cations 45 
according to the equation: 
G0s, Mn+  = Mn+ (1/ -1).            (3) 
In equation (3),  is dielectric constant of water (78.47 at 25 °C).  The parameter Mn+ is 
the Born solvation coefficients for aqueous cations and can be calculated by: 
 Mn+ = absMn+ - nabsH+.        (4) 
In equation (4), absH+ is the absolute Born solvation coefficient of H+ (53.87 kcal/mole), 
and absMn+ is the absolute Born solvation coefficients of the cations with the effective 
electrostatic radii of aqueous ions (re, Mn+). They can be calculated by  
absMn+ = 166.027 n2/( re, Mn+),        (5)  
re, Mn+ = rMn+ + n 0.94.         (6)  
The radii and non-solvation energies of trivalent and divalent cations 49, 50are listed in 
Table 1 and Table 2.  The Gibbs free energies of metal cations (G0f, Mn+) basically 
increase with decreasing hardness of Pearson’s Lewis acids. We may define cations with 
positive G0f, Mn+ to be soft acids, and those with negative G0f, Mn+ to be hard acids as 
discussed below.  
 
Results and Discussions 
All the data used for regression analysis are effective binding constants that have 
been corrected for bicarbonate concentration by the equation 40, 52:  
logK = logK* - logα          (7) 
where, 
 α = Kc [HCO3-] / (1+ Kc [HCO3-]).        (8) 
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The value of Kc for the both binding sites is 102.5 52.  
  
Equation (1c) has been applied to M3+—hTF (log K1) and M3+—(M3+-hTF) (log K2) 
complexes as well (Table 1).  The coefficients of a*ML, *ML, and b**ML can be 
obtained by regression analysis using experimental data measured at a neutral pH 
condition (see Table 1 for detail). Standard errors for log K1 and log K2 values are ±0.54 
and ±0.76, respectively.  Standard error for a well-studied ligand NTA is ±0.36 (Table 1). 
The discrepancies between measured and calculated values are generally within 0.6 log 
units (Figure 2).  Only Sc3+ data was not used for regression analysis, because of 
anomalously large discrepancies (2-3 log units) between the measured and the calculated 
values (Table 1). There are two sets of data for Al. The data by Harris and Sheldon 52 are 
very close the calculated values (Table 1).  The log K1 value by Martin et al is off by ~2 
log units 53. There are multiple sets of reported data for Tb (11.2, 7.61; 10.96, 8.52) 40. 
The most recent published values (9.96, 6.37) listed in Table 1 are used for regression 
analysis 54. It may be necessary to re-determine the binding constants for Sc3+, because 
there are large discrepancies among experimentally measured values similar to Tb and Al 
40 17.   
Table 1:  Ionic radii, thermodynamic data for trivalent cations, and stability constants 
for three families of metal complexes. 
 
Insert Table 1 Here 
 
Note: hTF = human serum transferring; NTA = Nitrilotriacetic acid (C6H9O6N) 
Note: Radii of the trivalent cations are from reference 50. The values of Gf of the 
cations are from references 51, 55 except for Bi3+ from reference 56, Ti3+ from 
reference 57 , and Pu3+, Np3+, and Am3+ from references 58 59.  The log K values of 
Fe—hTF are from references 13; the values of Bi—hTF, Ga—hTF, and In—hTF are 
from references 15, 60 61 62; the values of Al—hTF are from references 53 52; the 
values of Nd—hTF and Sm—hTF are from reference 42; the values of Lu—hTF and 
Gd—hTF are from reference 40; the values of Tb—hTF (in bolder) are from 
reference 54; the values of Sc—hTF are from reference14.  All the data of metal 
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complexes of rare earth elements with CO32- and HCO3- are from reference 63.  The 
data of other metal complexes of rare earth elements and CO32- are from reference 
64. The thermodynamic data for aqueous Ru3+ is from reference 65 with large 
uncertainty (~ 4.7 kcal/mole).   The free energy units are in kcal/mole.  Data in 
parentheses are not used for regression analyses. The data for NTA is from 
reference 66.  
 
 
 
Figure 2: Linear free energy relationship of equation (1d) for M3+—hTF (upper plot, 
logK1) and M3+— (M3+- hTF) (lower plot, logK2) complexes.    
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Figure 3: Linear free energy relationship of equation (1d) for M2+—hTF (upper plot, log 
K1) and M2+— (M2+- hTF) (lower plot, log K2) complexes.    
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Table 2:  Ionic radii, thermodynamic data for divalent cations, and stability constants 
for metal—hTF, metal— carboxy-peptidase,  and metal—ATP complex / 
chelate  families.  
 
Insert Table 2 Here 
 
Note: Radii of the cations are from references 45, 49, effective radii of NpO22+, PuO22+, 
and AmO22+ are assumed similar to that of UO22+.  The values of Gf of the cations 
are from reference 45 except for NpO22+ from reference 58, and Pt2+, Pd2+, PuO22+ and 
AmO22+ from reference 67. The log K values of Mn—hTF, Zn—hTF, and Cd—hTF are 
from references 68 16 69; the values of and Cu—hTF are from reference  70; the values 
of and Ni—hTF are from reference 41.  The values of log K metal—ligand complexes 
are from reference 66. The log K values of M — carboxy-peptidase are from 
reference71. 
 
The equation (1c) also applies to M2+—hTF (log K1) and M2+—(M2+-hTF) (log K2) 
complexes as well (Figure 3, Table 2).  There are two sets of data for Zn.  We used the 
values selected by Harris 62 (Table 2). Standard errors (±0.16 and ±0.27) for the divalent 
cations are low due to limited experimental data.  Only Ni2+ data were not used for 
regression analysis, because of anomalously large discrepancies between the measured 
and calculated values. The predicted values of logK1 and logK2 for Ni2+ are 9.6 and 7.9 
respectively.  By comparing the stability constants for Cu2+ and Co2+, it is expected that 
the predicted stability constants for Ni2+ are between those for Cu2+ and Co2+ based on 
their positions in the Periodic table. It was explained that distortion of the octahedral site 
may result in the reduction of stabilization energy of the Ni2+ 41. We do not think this 
would cause such a large discrepancy. One possibility for the large difference between 
measured and calculated values is the coordination environment for Ni is different than 
for other divalent cations. This has been observed in divalent cations in calcite (C. N. = 6) 
and aragonite (C. N. = 9) polymorphs 47.  Future experimentation using different methods 
may be helpful to solve this problem. The equation also fits the experimentally 
determined stability constants of inorganic and organic metal complex families (Tables 1, 
2, and 3), thus demonstrating the robustness of the proposed linear free energy 
relationship.  Using the obtained a*ML, b**ML, and *ML values, the unknown stability 
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constants metal—hTF complexes can be calculated (Table 1, Table 2).  Given limited 
data availability for the divalent metals, the resulting predicted values should be 
considered as the first order approximation of the stability constants.   
 
Our model shows that trivalent cations of Au3+, Tl3+, Co3+, V3+, In3+, Bi3+, Cr3+, and 
Mn3+ tend to compete with Fe3+. The stability constants of Tl3+, Ru3+, Au3+ and Co3+ are 
higher than that of Fe3+.  It is reported that Co3+—hTF complex is more stable than Fe3+—
hTF complex 72.  If Co3+ is reduced to Co2+, the stability constant of the Co2+—hTF 
complex will be much lower than that of the Co3+—hTF complex.  The binding strengths 
for Ru3+ (logK1 = 23.8 and logK2 = 23.0) are also predicted because Ru3+-complexes were 
suggested as a potential anti-cancer agent 24 26 28 29 73. It was suggested that compounds of 
Ru can be administered in Ru3+ oxidation state (relatively inert), causing minimal damage 
to healthy cells, but being reduced to active in Ru2+ oxidation state in cancer cells 74, 75. The 
new binding constants may be used for calculating  partitioning of  between the Ru3+-
complexes and Ru3+—hTF.   Because of relatively strong binding between Tl3+ and hTF 
and between Co3+ and hTF, Tl3+ and Co3+ can compete with Fe3+ in the Fe3+—hTF 
complex.  The predicted values of logK1 and logK2 for Hg2+ are 11.1 and 10.3 respectively.   
 
The linear free energy relationship can be used to predict the binding strengths of 
actinides to human serum transferring, which are difficult and dangerous to obtain 
experimentally 43, 76. The predicted stability constants for Cm3+—hTF and Cm3+—(hTF-
Cm3+) complexes are 8.7 and 6.4 respectively. The predicted stability constants for Am3+—
hTF and Am3+— (hTF-Am3+) complexes are 8.2 and 6.0 respectively (Table 1).  The 
values obtained here are larger than those predicted by Harris (1986) 41. Using the obtained 
coefficients for divalent and trivalent cations (Table 3), we can also estimate the 
coefficients for tetravalent cations like U, Th, and Hf. There are very limited data for 
tetravalent cations. The behaviors of tetravalent cations may be different from those of 
trivalent cations 77.   Early results show that Ti may binds stronger that ferric Fe 78. The 
coefficient *ML is proportional to the cation charge. Using available thermodynamic 
properties of tetravalent cations (Table 4), and the stability data for the Pu-hTF complex 
(log K1 = 21.25±0.75) 43 and the Ti-hTF complex (log K1 = 26.8) 79, it is possible to 
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estimate the stability constants for other tetravalent cations if we can estimate values of 
*ML or a*ML. The value of *ML is related to ion charges based on regression values 
(Table 3). Based on *ML values for divalent cations and trivalent cations, we estimated a 
value of 150 kcal/mole (very similar to that for EDTA listed in Table 3) for the coefficients 
*ML, for tetravalent cations. We can calculate the coefficient of a*ML to be 0.9563. The 
predicted stability constants for tetravalent cations are listed in table 4.  The predicted 
stability constant for U-hTF complex is about 20. That is slightly lower than the value for 
the Fe3+-hTF complex (Table 4). It is reported that the binding of the tetravalent cations 
(Ce, Hf, and Pu) could prevent normal closure of the transferrin interdomain cleft 80-82. It is 
proposed that the cations with large hydration or solvation energies (like tetravalent 
cations) may attract water molecules at the binding sites, which affects the normal closure 
of the transferring domains 40.  
 
Table 3:  Summary of regression coefficients for hTF and some metal complex families. 
Insert Table 3 Here 
 
Table 4: Table 4: Ionic radii, thermodynamic data for tetravalent cations, and predicted 
conditional stability constants of the M4+-hTF complex. 
 
Insert Table 4 Here 
Note: Thermodynamic properties of tetravalent cations are from references 46, 50 51. Gibbs 
free energies of formation (Gf) for M4+-oxides are from references 58, 83, and 84 are 
also listed as an example. The predicted difference is small. Only stability data for 
Pu-hTF complex (21.25±0.75) 43 and Ti-hTF (26.8) 79 are available and used to 
constrain coefficient b**ML. Experimental data of Pu-hTF and Ti-hTF are in bold.  
 
 
With the calculated values, we can also estimate redox potentials for M-hTF with 
different oxidation states, such as, Fe3+-hTF and Fe2+-hTF using Nernst equation 
 
E = 0.770 – 0.059 log (Kc-Fe3+ / Kc-Fe2+),      (9) 
 
Where 0.770V is the formal potential of the ferric to ferrous couple, and (Kc-Fe3+ / 
Kc-Fe2+ are the site-specific binding constants for ferric and ferrous ion, respectively 16.  
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As opposed to purely empirical methods, the linear free energy equation established 
above has a clear physical meaning for each term and thus provides a mechanistic basis for 
data extrapolation and interpolation.  By substituting equation (2) into (1c), the following 
relationship can be obtained: 
 
2.303RTlogKML = (1 - a*ML)G0f, Mn+ - b**ML  -  *ML rMn+  + a*MLG0s, Mn+.   (10) 
 
Interestingly, Gibbs free energies of formation of cations (G0f, Mn+) can be used as an 
index for the hardness/softness of metal cations (i.e., Lewis acids) proposed by Pearson 85, 
86. The more negative the value of the Gibbs free energy, the harder the acid will be.  It is 
logical to postulate that the coefficient a*ML or term 1-a*ML characterizes the softness or 
hardness of complexing ligands (bases).  A positive value of (1-a*ML) indicates a soft base 
or ligand, and a negative value of (1-a*ML) indicates a hard base or ligand. Therefore, the 
coefficient a*ML can be used as an index of the hardness of ligands. Soft bases have values 
of a*ML < 1; and hard bases have values of a*ML > 1. Because of the correlation from the 
above equation, one is able to, as opposed to previous qualitative and or arbitrary 
numbering scales of hardness/softness, definitively express the hardness/softness based on 
the value of a*ML relative to 1.  
 
Overall, the stability constants are determined by both ionic radii of metal cations, hardness 
of cations (acids) and ligands (bases). The solvation energy (G0s, Mn+) term is also related 
to the radii of cations. Similarly, the coefficient *ML reflects the coordination 
environments of cations or the structural effects from metal-ligand binding. The term 
*MXvrMn+ is similar to the steric effect; a large *ML value indicates a smaller coordination 
environment (polyhedron).  
 
Previously proposed linear free energy relationships are based on M-hTF and 
metals with other ligands 5, 14, or they correlate logK values for one metal cation with logK 
values for another metal cation 41. It is impossible to estimate logK for an element (like 
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Ru3+) without a known logK value with other ligand. Based on our linear free energy 
relationship, however, the logK values are determined by both the size and the energy 
(G0n, Mn+) of cations only. The previous methods may produce large uncertainties if they 
do not account for the effects from ionic radii and non-solvation energies. We can correlate 
the logK for M-hTF with logK for other metal-ligands using the obtained relationship. For 
instance, the difference between logK for hTF and logK for NTA (nitrilotriacetic acid) can 
be illustrated by using equation (1c): 
logKhTF = -(a*hTF G0n, M3+ + b**hTF +*hTF rM3+  - G0f, M3+ ) / 2.303RT  (11) 
logKNTA = -(a*NTA G0n, M3+ + b**NTA +*NTA rM3+  - G0f, M3+ ) / 2.303RT  (12) 
2.303RT (logKNTA - logKhTF) = (a*hTF - a*NTA) G0n, M3+ +(*hTF-*NTA  ) rM3+ 
     + (b**hTF - b**NTA), or   (13) 
2.303RT (logKNTA - logKhTF) = Δa*G0n, M3+ +Δ* rM3+ + Δ b**.   (14) 
Using the coefficients in table 3, we can get 
2.303RT (logKNTA - logKhTF) = -0.0312G0n, M3+ + 14.5 rM3+ - 7.44.   (15) 
The relationship can be schematically illustrated in Figure 4. For this particular case (see 
Table 3 for values of all coefficients), negative Δa* means NTA prefers hard acid (i.e., 
cations with large negative values of G0f, Mn+, such as rare earth elements and actinides); 
positive Δ* indicates that NTA (with lower * value) prefers to bind large cations; 
Negative Δ b** value means that hTF binds metals stronger than NTA does.  However, in 
order to obtain a good correlation for the previous methods, we would need to find a ligand 
with same or close *ML without explicitly considering effects from radii of cations. The 
previous relationship overestimates logK values for large ions like rare earth elements 
because of the term Δ* rMn+, and underestimate logK values for small ions, thus 
neglecting the importance of ionic radii. 
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Figure 4: Diagram illustrates the binding strength relationship between M-hTF and M-
NTA for trivalent cations. Both size and non-solvation energy of trivalent cations 
affect the difference between their stability constants.  
 
The Fe3+-hTF complex binds strongly to a receptor protein on the surface of cells.  
Inside the cell, the pH is lowering from 7.4 (extracellullar) to about 5.5 may cause the 
release of Fe3+ from the Fe3+—hTF complex 2, 3 6, 10, 11 ,13.  There are four proposed 
mechanisms for the release of Fe3+ inside the cell 1, 2.  The four are acidification, ligand 
exchange, reduction of Fe3+, and synergistic anion exchange 2. The reduction mechanism 
explains Fe well 87 88, but not for the non-redox elements.  A recent molecular dynamic 
modeling result indicates that the pH dependent change in the dynamics is traced to the 
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altered electrostatic potential distribution along the surface 89. It was proposed that 
protonation of carbonate 10, protonation of His 249 11, and both carbonate and His 249 
ligand protonation 6 are key steps in iron release.  According to our linear free energy 
relationship for ligands and protonated ligands, we propose that the protonation of a ligand 
(e.g., ATP, and carbonate) can result in hardness increasing (i.e., larger a*ML value) 
besides overall binding strength decrease (Table 3), which can lower the stability constants 
of soft acids (i.e., cations with high Gibbs free energy of formation in here) dramatically85.  
We can apply this concept to protonated hTF (or the formation of the H-hTF protein 
ligand) in acidic inside cell environment, which can lower the stability constant (log K) of 
the M3+—H-hTF complexes for the soft acids like Fe3+ dramatically and result in M3+ being 
released from the M3+—H-hTF complex.  The protonation of ligand hTF is similar to the 
mechanism of acidification. The protonation of a ligand decreases stability of protonated 
metal complexes.  For instance, in basic environment, CO2 in water is dominated by CO32- 
ligand. As the pH of a solution decreases, the CO32- ligand becomes protonated (or, ligand 
HCO3- will form). The protonated carbonate HCO3- ligand is harder than the unprotonated 
CO32- ligand (i.e., larger a*ML value with respect to that of carbonate ligand, Table 3). We 
propose that the overall function of hTF ligand in basic and acidic solutions is similar to the 
protonation of CO32- ligand, even though the function and property of the synergistic anion 
CO32- is not the same as that of isolated CO32-.  Such kind of a transformation mechanism 
may be useful for designing engineered proteins that can uptake toxic metals in a relatively 
basic solution and release the coordinated metals in a relatively acidic solution.   
 
Conclusions 
 The linear free energy relationship developed here can be used to predict 
unknown stability constants of metal—hTF protein complexes from limited experimental 
data. The discrepancies between the predicted and experimental data are generally less 
than 0.6 log units, far better than other empirical methods.   The stability constants for 
actinides (e.g., Pu and Am) and tetravalent cations are also predicted.  This relationship 
can be applied to the binding between metal cations and enzymes, and between metal 
metals and engineered proteins reported by Vita et al. 90.  It can also be used to 
systematically evaluate the quality of data collected from multiple sources and to select 
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internally consistent and reliable data sets for metal speciation in physiological fluid. It is 
also proposed that the release of Fe3+ inside cells results from protonation of the protein 
hTF and formation of the harder ligand H-hTF with a large a*ML value that reduces the 
binding strength of soft Lewis acids like Fe3+ dramatically.  The proposed method can be 
used as a guideline for designing engineered proteins and compounds with desired 
selectivity and strength 91, 92 93.  
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Table 1: Ionic radii, thermodynamic data for trivalent cations, and stability constants for three families of metal complexes.  
                    
      log KML      
  
M3+ rM3+ 
       (Å) 
Gs 
M3+ (aq) 
Gf 
M3+ (aq) 
Gn 
M3+ (aq) 
M—hTF
(Exper.) 
M—hTF
(Calc. ±0.54)
M—(hTF-M)
(Exper.) 
M—(hTF-M)
(Calc. ±0.76)
(M—CO3)+
(Exper.) 
(M—CO3)+
(Calc. 
±0.24)
M-NTA
(Exper.) 
M-NTA
(Calc. 
±0.36)
 
Al 0.53 -288.10 -115.38 172.73 12.4; 13.72 14.63 11.8; 12.72 12.98 8.43 8.41  10.49
Cr 0.62 -276.92 -51.50 225.42  18.40  17.12 8.97  13.91
Fe 0.65 -273.11 -4.12 268.99 21.90 21.06 20.60 20.08 9.72 9.38 15.90 15.87
Co 0.63 -275.01 32.03 307.04  23.16  22.43 9.71  16.94
Ga 0.62 -276.28 -38.00 238.28 19.75 19.17 18.80 17.98 8.72 9.09 13.80 14.43
Ti 0.76 -259.08 -83.60 175.48  15.96  14.34 8.52  14.05
V 0.64 -273.74 -57.90 215.84  18.00  16.66 8.90  13.98
Mn 0.58 -281.46 -20.30 261.16  20.18  19.14 9.26  14.52
Sc 0.81 -253.25 -140.20 113.05 (14.60) 12.30 (13.30) 10.25 7.91 12.70 12.31
Tl 0.95 -237.77 51.30 289.07  21.46  20.62 9.27  18.84
Bi 0.96 -236.71 19.79 256.50 19.42 19.50 18.58 18.45 8.96 18.20 17.73
In 0.81 -253.25 -23.40 229.85 18.30 18.96 16.60 17.72 8.96  16.31
Y 0.92 -240.99 -163.80 77.19  9.62  7.34 6.94 7.43 11.47 11.56
La 1.14 -218.51 -164.00 54.51  5.58  3.14 6.82 6.64 10.47 10.22
Ce 1.07 -225.39 -161.60 63.79  7.19  4.81 6.95 6.94 10.70 10.92
Pr 1.06 -226.39 -162.60 63.79  7.33  4.95 7.03 6.97 10.87 10.96
Nd 1.04 -228.41 -160.60 67.81 7.33 7.82 6.28 5.47 7.13 7.06 11.10 11.17
Pm 1.06 -226.39 -158.00 68.39  7.59  5.24 7.22 7.01  11.12
Sm 1.00 -232.52 -159.10 73.42 8.37 8.63 6.63 6.32 7.30 7.22 11.32 11.45
Eu 0.98 -234.60 -137.30 97.30 9.66 10.21 7.27 8.06 7.37 7.48 11.32 12.28
Gd 0.97 -235.65 -158.60 77.05 9.20 9.16 7.18 6.87 7.44 7.32 11.35 11.59
Tb 0.93 -239.91 -159.50 80.41 11.2;10.96; 9.96 9.73 8.52; 7.61; 6.34 7.46 7.50 7.44 11.50 11.68
Dy 0.92 -240.99 -158.70 82.29  9.92  7.66 7.55 7.47 11.63 11.73
Ho 0.91 -242.08 -161.40 80.68  9.90  7.64 7.59 7.48 11.76 11.66
Er 0.89 -244.26 -159.90 84.36  10.26  8.02 7.63 7.55 11.90 11.73
Tm 0.87 -246.59 -159.90 86.69  10.52  8.30 7.66 7.60 12.07 11.73
 25 
 
Yb 0.86 -247.81 -153.00 94.81  11.05  8.88 7.67 7.69 12.21 11.96
Lu 0.85 -248.94 -159.40 89.54 11.08 10.80 7.93 8.59 7.70 7.66 12.32 11.73
U 1.12 -220.45 -113.88 106.57 8.88  6.80 7.17 12.13
Pu 1.08 -224.39 -138.15 86.24  8.33  6.11 7.12 11.65
Np 1.10 -222.41 -123.59 98.82 8.75  6.61 7.17 11.98
Am 
Ac 
Cm 
Bk 
1.07 
1.20 
1.05 
1.04 
-225.39 
-212.80 
-227.40 
-228.41 
-143.19 
-152.96 
-142.40 
-138.86 
82.20
59.84
85.00
89.55
8.24
4.83
8.67
9.07
 5.99
2.42
6.44
6.86
(6.5) 7.11
6.47
7.19
7.26
11.50
11.80 
11.55
9.94
11.72
11.91
Au 
Ru 
0.85 
0.67 
-248.94 
-269.98 
103.60 
41.44 
352.31
311.42
25.79
23.60
 25.38
22.91
10.01
9.76
20.73
17.68 
                    
hTF = human serum transferring; NTA = Nitrilotriacetic acid (C6H9O6N) 
Note: Radii of the trivalent cations are from reference 50. The values of Gf of the cations are from references 51, 55 except for Bi3+ from 
reference 56, Ti3+ from reference 57 , and Pu3+, Np3+, and Am3+ from references 58 59.  The log K values of Fe—hTF are from references 13; the 
values of Bi—hTF, Ga—hTF, and In—hTF are from references 15, 60 61 62; the values of Al—hTF are from references 53 52; the values of Nd—
hTF and Sm—hTF are from reference 42; the values of Lu—hTF and Gd—hTF are from reference 40; the values of Tb—hTF (in bolder) are 
from reference 54; the values of Sc—hTF are from reference14. All the data of metal complexes of rare earth elements with CO32- and HCO3- are 
from reference 63.  The data of other metal complexes of rare earth elements and CO32- are from reference 64. The thermodynamic data for 
aqueous Ru3+ is from reference 65 with large uncertainty (~ 4.7 kcal/mole).   The free energy units are in kcal/mole.  Data in parentheses are not 
used for regression analyses. The data for NTA are from reference 66.  
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Table 2  Ionic radii, thermodynamic data for divalent cations, and stability constants for metal—hTF, metal— carboxy-peptidase, 
and metal—ATP complex / chelate  families.  
                     
         log KML      
 
M2+ rM2+ 
       (Å) 
Gs 
M2+(aq) 
Gf 
M2+(aq) 
Gn 
M2+(aq) 
M—hTF 
(Exper.) 
M—hTF 
(Calc. 
±0.16) 
M— 
(M-hTF) 
(Exper.) 
M— 
(M-hTF) 
(Calc. ±0.27)
M—
ATP 
(Exper.)
M—ATP
(Calc. 
±0.28) 
M— 
 (H-ATP) 
  (Exper.)    
M— 
 (H-ATP) 
 (Calc. ±0.19)
M-carboxy-
peptidase 
   (Exper.)    
M-carboxy-
peptidase 
 (Calc. ±0.94) 
 
Be 0.45 -175.02 -89.80 85.22 2.29  0.86 4.06 3.93 4.55 4.69  -11.86 
Mg 0.72 -145.80 -108.83 36.97 -0.03  -1.37 4.76 4.72 4.14 4.27  -5.34 
Ca 1.00 -121.28 -132.12 -10.84 -6.45  -7.70 4.85 4.91 4.35 4.18  -2.52 
Mn 0.82 -136.46 -55.20 81.26 4.06 4.26 2.96 3.00 3.77 3.76 4.69 4.79 4.60 4.20 
Fe 0.77 -141.04 -21.87 119.17 8.20  6.94 5.21 4.10  7.42 
Co 0.74 -144.35 -13.00 131.35 9.45  8.18 4.63 5.17 4.19 4.05 7.00 7.71 
Ni 0.70 -147.75 -10.90 136.85 (4.10) 9.96 (3.23) 8.68 5.02 5.14 4.23 4.06 8.20 7.05 
Cu 0.73 -144.83 15.55 160.38 12.26 12.36 11.08 10.11 6.13; 6.0 5.52 3.52 3.86 10.60 11.35 
Zn 0.75 -143.30 -35.17 108.13 7.42 7.19 5.91 5.91  3.49  5.04 (10.50) 5.10 
Sr 1.16 -109.30 -133.72 -24.42 -10.24  -11.42 5.10 4.08  -0.59 
Cd 0.95 -125.31 -18.57 106.74 5.95 5.89 4.86 4.70 3.54 3.61 5.04 4.92 10.80 11.63 
Sn 1.11 -112.91 -6.63 106.28 3.73 2.61 5.22 4.02  15.60 
Ba 1.36 -95.99 -132.73 -36.74 -15.72 -16.82 5.28 4.03  1.22 
Eu 1.17 -108.59 -129.10 -20.51 -10.02 -11.20 3.29 3.29 5.09 5.19  0.13 
Hg 1.02 -119.71 39.36 159.07 10.34 9.21 3.66 4.90 21.00 20.43 
Pb 1.18 -107.89 -5.79 102.10 2.09 1.00 5.93 3.67 16.52 
Ra 1.39 -94.14 -134.20 -40.06 -16.80 -17.89  3.21  5.25 1.19 
UO2 0.754 -142.54 -227.70 -85.16 -12.27 -13.68  2.47  5.45 -20.15 
NpO2 0.73 -148.60 -190.20 -41.60 -10.67 -12.05  2.53  5.50 -18.09 
PuO2 0.71 -150.59 -183.50 -32.91 -9.85 -11.24  2.59  5.48 -17.77 
AmO2 0.70 -151.60 -156.70 -5.10 -7.10 -8.48  2.91  5.32 -14.52 
Pd 0.80 -141.87 42.49 184.36 12.03 10.83  5.58  3.91 14.48 
Pt 0.80 -141.87 54.80 196.67 13.27 10.98  5.73  3.83 16.10 
                     
Note: Radii of the cations are from references 45, 49, effective radii of NpO22+, PuO22+, and AmO22+ are assumed similar to that of UO22+.  The values of Gf of 
the cations are from reference 45 except for NpO22+ from references 58, and Pt2+, Pd2+, PuO22+ and AmO22+ from reference 67. The log K values of Mn—hTF, 
 27 
 
Zn—hTF, and Cd—hTF are from reference 68 16 69; the values of and Cu—hTF are from reference  70; the values of and Ni—hTF are from reference 41;.  The 
values of log K metal—ligand complexes are from reference 66. The log K values of M — carboxy-peptidase are from reference 71. Values in parentheses are 
not used for regression analysis due to large difference between experimental and calculated values. The large difference for Zn-carboxy-peptidase between 
measured and calculated values may tell that the coordination environment for Zn is different from other divalent cations.  
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Table 3:  Summary of regression coefficients for hTF and some metal complex families. 
            
Metal complex type   Regression coefficients   
Mn+L     a*ML    b**ML    *ML      Data points 
 Divalent Cations 
M2+-Carboxypeptidase  0.8199 -162.89 43.1    6  
M2+—hTF 0.8632 -209.46 95.5    4  
M2+—(hTF-M2+) 0.8623 -207.17 94.9    4  
M2+—EDTA * 0.9046 -207.33 71.9    12  
M2+—ATP# 0.9749 -27.96 8.4    9  
M2+—(H-ATP)# 1.0090 +15.79 -8.7    9  
 Trivalent Cations 
M3+—hTF 0.9221 -357.79 119.2 11  
M3+—(hTF-M3+) 0.9128 -353.92 119.2  11  
M3+—EDTA *  0.9284 -350.35 107.8 26 
M3+—NTA *  0.9533 -350.35 105.7 22 
M3+—CO32+ 0.9894 -358.57 117.0 18   
M3+—HCO32+ 1.0300 -345.41 108.0 15   
 
 Tetravalent Cations 
M4+—EDTA * 0.9688 -527.42 153.5 4  
M4+—hTF 0.9563 -514.33 150.0    
      
Note: All values refer to standard condition (25°C, 1 bar).    
hTF = human serum transferring; NTA = Nitrilotriacetic acid (C6H9O6N) 
ATP = Adenosine 5’-triphosphate; H-ATP = protonated ATP 
* Use the available data for ionic strength of 0.1 for metal-EDTA and M3+—NTA chelates.  
# Aqueous M2+—ligand mono-dendate complexes require additional term from solvation energy  
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(cML • G0s, M2+) because of strong effect from solvent water, i.e.,  
G0f, ML = aML G0n, M2+ + cML G0s, M2+ + *ML rM2+ + bML, or  
2.303RTlogKML = (1 - aML)G0f, Mn+ - *ML rMn+  + (aML-cMLG0s, Mn+ - b**ML.  
The cML values for M2+—ATP and M2+—AH-TP are 0.9576 and 1.0180 respectively  
(see Xu et al., 2017)85 for details.  
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Table 4: Ionic radii, thermodynamic data for tetravalent cations, and predicted conditional stability constants of M4+-hTF complex 
                 
  Gf     calculated log K1 
 
 
M4+ 
rM4+ 
    (Å) 
Gs 
M4+(aq) 
Gf 
M4+(aq) 
Gn 
M4+(aq)  
MO2 
(experimental) 
MO2 
(calculated) 
M-hTF 
( *  = 150) 
 
Zr 0.79 -373.11 -141.00 232.11 -248.50 -249.26 23.44
Hf 0.78 -374.41 -156.80 217.61 -260.09 -259.32 23.13
Ce 0.94 -354.23 -120.44 233.79 -244.40 -243.32 20.83
Th 1.02 -344.65 -168.52 176.13 -279.34 -279.50 17.24
U 0.97 -350.60 -124.40 226.20 -246.62 -247.46 19.96
Np 0.95 -353.02 -120.20 232.82 -244.22 -243.66 20.59
Pu 0.93 -355.45 -114.96 240.49 -238.53 -239.14 21.25
Am 0.92 -356.68 -89.20 267.48 (-230; -210.4) -221.34 22.30
Po 1.06 -339.98 70.00 409.98  -121.13 23.65
Pb 0.84 -366.68 143.50 510.18  -60.87 31.44
Sn 0.71 -383.69 40.50 424.19  -122.79 30.55
Ti 0.68 -387.76 -93.00 294.76  -210.69 26.78
Mn 0.60 -398.88 58.00 456.88  -104.35 32.54
                 
Note: Thermodynamic properties of tetravalent cations are from references 46, 50 51. Gibbs free energies of formation (Gf) for  
M4+-oxides are from references 58, 83, and 84 are also listed as an example. The predicted difference is small. Only stability data for  
Pu-hTF complex (21.25±0.75) 43 and Ti-hTF (26.8) 79 are available and used to constrain coefficient b**ML. Experimental data of  
Pu4+-hTF and Ti4+-hTF are in bold cases.  
